x 

0 Activities
0 Activities
    • No Saved Activities

Please Note: These Activities are Not Available for Credit

Page 3 of 7
Results 151 - 225 of 464
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module
No image set
Cardiac Amyloidosis Webinar #4: Treatment of Cardiac Amyloidosis
No image set
Cardiac Amyloidosis Webinar #3: Establishing the Correct Diagnosis
No image set
Cardiac Amyloidosis Webinar #2: Cardiac Imaging Pearls
No image set
Cardiac Amyloidosis Webinar #1: Who Should I be Testing?
No image set
Updates in Diabetes Care for Primary Care Providers
No image set
Osteoporosis Updates: Primary Care’s Critical Role
No image set
Primary Care and Dyslipidemia: What Should You Do?
No image set
Staying Current in Obesity Management: Key Updates for Primary Care
No image set
Thyroid Assessment: Updates for Primary Care
No image set
A New Paradigm in Treating ILD
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
Exploring CGM: Achieving Treatment Goals Together
No image set
Reversing DOACS: Providing Answers to What, Where and How
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
LGMD: Mutation-specific Nomenclature
No image set
LGMD Symptomatology
No image set
LGMD Mutations and Disease Types
No image set
Tests and Outcomes - DMD
No image set
Genes, Exons, and the Pathophysiology of DMD
No image set
The Natural History of DMD
No image set
Reversing DOACS: Recording from Live Session held on July 18, 2021
No image set
Conquer the Clot: Addressing VTE in Your Patients with Cancer
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Updates in SMA: Cure SMA Conference Coverage (CME/CE)
9076-0001-263x149
Healthcare Disparities in African Americans With Myeloma
No image set
Beyond The Basics Of PAH
No image set
Pediatric GHD: Working Together To Ensure Success
No image set
New and Emerging Options for the Management of MS
No image set
Perioperative Nutrition and Wound Healing
No image set
Special Considerations for Nutrition for the Elderly
No image set
Diabetes & Nutrition
No image set
Comorbidities and Selection of DMTs
No image set
Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
Conference Coverage on DMD and LGMD: Latest Developments
No image set
Management of Breakthrough Disease Activity in MS
No image set
Key Considerations: Advances in Gene Therapy for Hemophilia
No image set
Highlights From the EAHAD 2021 Virtual Congress
No image set
Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)
No image set
First Data From the Phase 3 HOPE-B Gene Therapy Trial
No image set
The World Federation of Hemophilia Gene Therapy Registry
No image set
Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)
No image set
AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)
No image set
AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)
No image set
First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology
No image set
Characterisation of Adeno-Associated Virus Vector Persistence
No image set
Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a)
No image set
Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Drygalski)
No image set
Efficacy and Safety of Etranacogene Dezaparvovec in Adults
No image set
COVID-19 Associated ARDS
No image set
COVID-19 and Comorbid ILD
No image set
Minimizing Neurodegenerative Damage in Patients with MS
No image set
Recognizing Progressive Disease: A Challenge in the MS Clinic
No image set
Three Cases of Lung Fibrosis in Patients With COVID-19
No image set
Assessing a Patient With Long COVID-19
No image set
MDA Conference Coverage
No image set
Engaging Patients with MS and the Care Team in Shared Decision-Making
No image set
Advances in MS Assessment: Biomarkers and Imaging
No image set
Defining the Clinical Course of Multiple Sclerosis
No image set
Engaging the Patient in Treatment Choices
No image set
DMT Treatment Review
No image set
Thrombotic Thrombocytopenic Purpura (TTP) Podcasts
No image set
Approach to the Patient With Cancer-associated VTE
No image set
Understanding and Recognizing TTP
Page 3 of 7

Search